Back
Verve Therapeutics 10K Form
Sell
12
VERV
Verve Therapeutics
Last Price:
5.97
Seasonality Move:
80.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VERV News And Ratings
See the #1 stock for the next 7 days that we like better than VERV
VERV Financial Statistics
Sales & Book Value
| Annual Sales: | $11.76M |
|---|---|
| Cash Flow: | $-43.52M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.96 |
| Price / Book: | 0.86 |
Profitability
| EPS (TTM): | -2.87000 |
|---|---|
| Net Income (TTM): | $-196.83M |
| Gross Margin: | -- |
| Return on Equity: | -37.6% |
| Return on Assets: | -29.63% |
Verve Therapeutics Earnings Forecast
Key Verve Therapeutics Financial Ratios
- The Research & Development expenses have been 1,572.94% of Revenue.
- The Net Earning history of VERV is -1,701.55% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Verve Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VERV |
| Website: | vervetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 19.82 |
| Quick Ratio: | 19.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VERV Technical Analysis vs Fundamental Analysis
Sell
12
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a Sell
The current Verve Therapeutics [VERV] share price is $5.98. The Score for VERV is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.